Observation of Safety and Tolerability Within 1 Year of the Use of R-ketamine / Placebo in Drug-resistant Depression
NCT06232291 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3
Last updated 2024-05-29
Summary
An observational-comparative study, without interfering with the treatment, based on an operationalized interview.
Conditions
- Treatment-Resistant Depression
- Major Depressive Disorder
Sponsors & Collaborators
-
Perception Neuroscience
collaborator INDUSTRY -
Medical University of Gdansk
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-04-21
- Primary Completion
- 2024-05-24
- Completion
- 2024-05-24
Countries
- Poland
Study Locations
More Related Trials
-
Ketamine Infusion for Treatment-resistant Major Depressive Disorder
NCT01582945 ·Status: COMPLETED ·Phase: NA
-
Ketamine Treatment Effects on Synaptic Plasticity in Depression
NCT04091971 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Ketamine on Aesthetics and Role for Antidepressant Effects
NCT05320107 ·Status: RECRUITING ·Phase: PHASE1
-
Repeated Neurocognitive Measurements in Depressed Patients
NCT04916548 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Trial of the Use of Ketamine in Treatment Resistant Depression
NCT02610712 ·Status: UNKNOWN ·Phase: PHASE4
-
Patient Tolerability Study of GSK163090
NCT00559299 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD)
NCT03149991 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Lithium Versus Placebo in Adults With Treatment-Resistant Depression Who Are Receiving Ketamine
NCT03290963 ·Status: WITHDRAWN ·Phase: PHASE2
-
Ketamine Plus Lithium in Treatment-Resistant Depression
NCT01880593 ·Status: COMPLETED ·Phase: PHASE2
-
Ketamine for Major Depressive Disorder
NCT03721900 ·Status: UNKNOWN ·Phase: PHASE1
-
Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD)
NCT01920555 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of TAK-653 in Treatment-Resistant Depression
NCT03312894 ·Status: WITHDRAWN ·Phase: PHASE2
-
Ketamine Trial for the Treatment of Depression
NCT02401139 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of MK-1942 When Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression (TRD) (MK-1942-006)
NCT04663321 ·Status: TERMINATED ·Phase: PHASE2
-
Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With Ketamine
NCT05327699 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
The Relationship Among Changes in Brain Network Activation in Adult Outpatients With Major Depressive Disorder
NCT02749721 ·Status: COMPLETED ·Phase: PHASE4
-
Neurobiological Bases of Placebo Response in Major Depressive Disorder
NCT01787240 ·Status: TERMINATED ·Phase: PHASE4
-
Study of Depression-Ketamine-Brain Function
NCT01135758 ·Status: TERMINATED ·Phase: PHASE2
-
Escitalopram, Placebo and tDCS in Depression: a Non-inferiority Trial
NCT01894815 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate Evoked Potentials as Markers of Ketamine-induced Cortical Plasticity in Patients With Major Depressive Disorder
NCT01957410 ·Status: TERMINATED ·Phase: PHASE2
-
Neural Circuit Effects of Ketamine in Depression
NCT06213324 ·Status: RECRUITING ·Phase: PHASE4
-
Psilocybin Versus Ketamine in Treatment-Resistant Depression
NCT05383313 ·Status: UNKNOWN ·Phase: PHASE2
-
Ketamine Augmentation of ECT in Treatment-Resistant Depression
NCT07088380 ·Status: RECRUITING ·Phase: PHASE3
-
Effects of TAK-063 on Preventing Ketamine-Induced Brain Activity Changes as Well as Psychotic-Like Symptoms in Healthy Male Adults
NCT01892189 ·Status: COMPLETED ·Phase: PHASE1
-
Ketamine in Adolescents With Treatment-Resistant Depression
NCT02078817 ·Status: COMPLETED ·Phase: PHASE2